Bausch + Lomb, Year’s Second-Biggest IPO, Pops in Public Debut

This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers visit

  • Order Reprints

  • Print Article

Eye-care company Bausch + Lomb and biotech PepGen kicked off their lives as public companies Friday. 

The two companies opened during a slow time for new issues. Inflation, broad market volatility, and the war in Ukraine have caused IPOs to come to a near halt in 2022. Just 39 firms have gone public using traditional offerings as of May 6, raising $4 billion, according to Dealogic. This compares to 140 businesses, collecting $56.6 billion, for the same period in 2021. 


Roy Walsh

Related post